Fatal Yellow Fever in Travelers to Brazil, 2018

保存先:

書誌詳細
出版年:	MMWR. Morbidity and Mortality Weekly Report vol. 67, no. 11 (Mar 23, 2018), p. 340
第一著者:	Hamer, Davidson H, MD
その他の著者:	Angelo, Kristina, DO, Caumes, Eric, MD, van Genderen, Perry J J, MD, PhD, Florescu, Simin A, MD, PhD, Popescu, Corneliu P, MD, Perret, Cecilia, MD, McBride, Angela, BMBS, Checkley, Anna, MBChB, DPhil, Ryan, Jenny, MBBS, Cetron, Martin, MD, Schlagenhauf, Patricia, PhD
出版事項:	U.S. Center for Disease Control
主題:	Boston University International Society of Travel Medicine Public Health England World Health Organization University of Zurich Boston Medical Center Pontificia Universidad Catolica de Chile Food & Drug Administration > FDA University College London Hospitals Department of Health & Human Services Ilha Grande United Kingdom > UK Peru Africa Argentina Brazil Rio de Janeiro Brazil France Atlanta Georgia Switzerland Netherlands United States > US New York Massachusetts Romania South America Chile Vaccines Flavivirus Fever Viruses Outbreaks Immunization Primates Urban environments Travel Tropical diseases Infectious diseases Urban areas Vector-borne diseases Illnesses Avoidable Mosquitoes Yellow fever Patients
オンライン･アクセス:	Citation/Abstract Full Text Full Text - PDF
タグ:	タグ追加タグなし, このレコードへの初めてのタグを付けませんか!

その他の書誌記述
抄録:	Yellow fever virus is a mosquito-borne flavivirus that causes yellow fever, an acute infectious disease that occurs in South America and sub-Saharan Africa. Most patients with yellow fever are asymptomatic, but among the 15% who develop severe illness, the case fatality rate is 20%-60%. Effective live-attenuated virus vaccines are available that protect against yellow fever. An outbreak of yellow fever began in Brazil in December 2016; since July 2017, cases in both humans and nonhuman primates have been reported from the states of Sao Paulo, Minas Gerais, and Rio de Janeiro, including cases occurring near large urban centers in these states. Yellow fever is a potentially fatal illness that is preventable by vaccination. Yellow fever vaccination is recommended for all eligible persons aged ≥9 months, traveling to many areas in Brazil, including the states of Sao Paulo and Rio de Janeiro (especially Ilha Grande).
ISSN:	0149-2195 1545-861X 0091-0031
ソース:	Healthcare Administration Database